Lubiprostone-d7
Product Code
TRC-L473503
CAS Number
Product Format
Neat
Molecular Formula
C20H25D7F2O5
Molecular Weight
397.51
API Family
LubiprostoneProduct Categories
Chiral Molecules , TRC, API Reference Standards & Research Materials, Ion channel modulators, Transporter modulators & probes, Other ion channels, Epilepsy, Nociception, Stroke, Neuroinflammation Research Chemicals & Analytical Standards, Neuroinflammation Research Chemicals & Analytical Standards, Pain and Inflammation, Stable isotopes, Stable Isotope Labelled Analytical Standards
Unlabelled CAS Number
Documentation
Looking for another lot?
To view all certificates of analysis immediately, please login to your account
or
{{ errors.first('lotNumber') }}
{{ errors.first('requestEmail') }}
For information about our data processing activities, please visit our Privacy Notice.
Enter your email address and we'll email you the relevant CoA for lots:
{{ coaPopupData.packSize.coaSelectedLotNumbers }}
{{ errors.first('coaEmail') }}
We will be sending the CoA to your email address {{ coaEmailPopupData.userEmail }}
Your request has been sent to our sales team to process.
Find an SDS for your region
{{ errors.first('selectedRegion') }}
{{ errors.first('sdsEmail') }}
For information about our data processing activities, please visit our Privacy Notice.
Your request has been sent to our sales team to process.
Product Information
Chemical Data
Analyte Name
Lubiprostone-d7
CAS Number
1217675-13-2
Molecular Formula
C20H25D7F2O5
Molecular Weight
397.51
SMILES
O=C(C(F)(F)CC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])CC[C@@H]1[C@@H](CCCCCCC(O)=O)C(C[C@H]1O)=O
Unlabelled CAS Number
136790-76-6
SIL Type
Deuterium
Product Data
Storage Temperature
-20°C
Shipping Temperature
Room Temperature
Country of Origin
CANADA
Product Type
Stable Isotope Labelled; Metabolite; API
Product Format
Neat
API Family
Product Description
Labelled Lubiprostone is a bicyclic fatty acid metabolite analog of Prostaglandin E1. It activates specific chloride channels in the gastrointestinal tract to stimulate intestinal fluid secretion, increase gastrointestinal transit, and improve symptoms of constipation.
References: Farthing, M., et al.: Drugs, 56, 11 (1998), Pare, P., et al.: Am. J. Gastroenterol., 96, 3130 (2001), Sloots, C., et al.: Aliment. Pharmacol. Ther., 16, 759 (2002), Coremans, G., et al.: Digestion, 67, 82 (2003),